Scientists discover new Alzheimer's gene

Aug 07, 2009
Scientists discover new Alzheimer's gene
A new study by Dr. Steven Potkin reports that a gene called TOMM40 appears twice as often in people with Alzheimer's disease than in those without it. Photo by Daniel A. Anderson / University Communications

(PhysOrg.com) -- A UC Irvine study has found that a gene called TOMM40 appears twice as often in people with Alzheimer's disease than in those without it. Alzheimer's, for which there is no cure, is the leading cause of elderly dementia.

Having the harmful form of TOMM40 significantly increases one's susceptibility when other risk factors - such as having a gene called ApoE-4 - are present, the new study reports. People who have ApoE-4 are three to eight times more likely to develop Alzheimer's.

"The TOMM40 gene influences the ease with which molecules can get in and out of mitochondria, the energy production center and mediator of cells. TOMM40 also processes materials that form amyloid plaque, a hallmark of Alzheimer's," said Dr. Steven Potkin, lead author of the study and UCI & human behavior professor.

"With aging, the number and function of mitochondria decrease, accompanied by a parallel increased risk of developing Alzheimer's," he said. "This study points to the use of mitochondrial-based therapies for treating the disease."

The study will be published Aug. 7 in the journal PLoS One.

Supporting the UCI discovery is research presented recently at the International Conference on Alzheimer's Disease in Austria. Duke University scientists found that patients with TOMM40 developed Alzheimer's an average of seven years earlier than those without the gene.

Source: University of California - Irvine

Explore further: Changes in scores of genes contribute to autism risk

add to favorites email to friend print save as pdf

Related Stories

Having a parent with dementia may affect memory in midlife

Feb 18, 2009

People who have parents diagnosed with Alzheimer's disease or dementia may be more likely to have memory loss themselves in middle age, according to a study released today that will be presented at the American Academy of ...

Researchers find parental dementia may lead

Feb 19, 2009

People who have parents diagnosed with Alzheimer's disease or dementia perform less well on formal memory testing when compared to people of the same age whose parents never developed Alzheimer's disease or other dementia. ...

Gene tests and brain imaging reveal early dementia

Mar 06, 2007

Dementia diseases develop insidiously and are generally discovered when the memory has already started to deteriorate. New research form Karolinska Institutet shows, however, that approaching Alzheimer's can be detected several ...

Recommended for you

Changes in scores of genes contribute to autism risk

Oct 29, 2014

Small differences in as many as a thousand genes contribute to risk for autism, according to a study led by Mount Sinai researchers and the Autism Sequencing Consortium (ASC), and published today in the journal Nature.

Dozens of genes associated with autism in new research

Oct 29, 2014

Two major genetic studies of autism, led in part by UC San Francisco scientists and involving more than 50 laboratories worldwide, have newly implicated dozens of genes in the disorder. The research shows ...

Genetic link to kidney stones identified

Oct 29, 2014

A new breakthrough could help kidney stone sufferers get an exact diagnosis and specific treatment after genetic links to the condition were identified.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

kylie_icarastudy
not rated yet Aug 07, 2009
Any research that provides additional insight into Alzheimer%u2019s is critical to finding a cure.
Current therapies treat the symptoms associated with it, not the disease itself. Clinical studies that test potential new treatments are the best chance we have for fighting this disease. Patients and families affected by Alzheimer%u2019s can visit www.icarastudy.com to see if they%u2019re eligible to enroll in the ICARA Study, whose goal is to explore if an investigational drug, called bapineuzumab, can help slow the progression of Alzheimer's.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.